Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Japan

Takeda Acquires Rights To Amgen Drugs

February 2008 | Company News Alert

Japanese firm Takeda is to develop and commercialise up to 13 molecules from US-based Amgen's pipeline for its domestic market. Amgen will receive US$200mn upfront, US$702mn in milestone payments and double-digit royalties on sales. Ownership of Amgen's subsidiary in Japan will be also transferred to Takeda.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Abbott Expects To Outperform Market

Industry / Japan Following the launch of its breakthrough rheumatoid arthritis therapeutic, US drugmaker Abbott Laboratories is looking to outperform the Japanese patented drug sector over the next two years. By 2010,...
June 2008
Zydus Cadila Acquires Nippon Universal Pharmaceutical

Companies / Japan In an effort to penetrate the under-developed Japanese generics market, Indian firm Zydus Cadila has bought local player Nippon Universal Pharmaceutical. While a prescient move in our opinion, we believe...
April 2007
Speculation Mounts Over Mitsubishi/Tanabe Merger

Companies / Japan Local press, analysts and the companies themselves have increasingly commented on the possible integration of Japanese drugmakers Mitsubishi Pharma and Tanabe Seiyaku. Tanabe would acquire Mitsubishi...
January 2007
Renewed Speculation Over Japan's Sawai

Companies / Japan Local media sources have again claimed that the world's largest generic drugmaker, Israel-based Teva, is concisidering a bid for leading Japanese generics firm Sawai. Other international producers including...
June 2006
Speculation Links Astellas, Serono

Companies / Japan Reports in the international media have prompted Astellas, Japan's third-largest drugmaker, to deny claims that the company is to use a US$8.6bn loan to acquire Swiss biotech Serono. However, officials...
March 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS